Prediction and Evaluation by ETCOc of Neonatal Hyperbilirubinemia Cohort

RecruitingOBSERVATIONAL
Enrollment

2,700

Participants

Timeline

Start Date

December 11, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Neonatal JaundiceNeonatal HyperbilirubinemiaHemolysis Neonatal
Interventions
DIAGNOSTIC_TEST

End-tidal carbon monoxide-corrected (ETCOc)

Early postnatal ETCOc levels

Trial Locations (7)

510010

NOT_YET_RECRUITING

Guangdong Maternity and Child Healthcare Hospital, Guangzhou

510080

NOT_YET_RECRUITING

The First affiliated Hospital, Sun Yat-sen University, Guangzhou

510623

RECRUITING

Guangzhou Women and Children's Medical Center, Guangzhou

510632

NOT_YET_RECRUITING

The First Affiliated Hospital of Jinan University, Guangzhou Overseas Chinese Hospital, Guangzhou

518000

NOT_YET_RECRUITING

Shenzhen Maternity and Child Healthcare Hospital, Shenzhen

523700

NOT_YET_RECRUITING

Dongguan Maternity and Child Healthcare Hospital, Dongguan

528300

NOT_YET_RECRUITING

Foshan Shunde Women and Children Health Care Hospital, Foshan

All Listed Sponsors
lead

Guangzhou Women and Children's Medical Center

OTHER

NCT06341582 - Prediction and Evaluation by ETCOc of Neonatal Hyperbilirubinemia Cohort | Biotech Hunter | Biotech Hunter